Associations between hydroxychloroquine dose and risk of flares in systemic lupus erythematosus

Related articles

1. COVID-19 is associated with lupus flare and persistent disease activity: longitudinal data from the ReumaCov-Brazil Register study

   This article has 29 authors:

   1. Joana Starling de Carvalho
   2. Edgard Torres dos Reis Neto
   3. Adriana M. Kakehasi
   4. Sandra L. E. Ribeiro
   5. Samia A. S. Studart
   6. Francielle P. Martins
   7. Rafaela Cavalheiro do Espírito Santo
   8. Aline Ranzolin
   9. Diana C. Fernandino
   10. Valquiria G. Dinis
   11. Emília I. Sato
   12. Gustavo G. Resende
   13. Adriana Marinho
   14. Henrique Ataide Mariz
   15. Nathália de Carvalho Sacilotto
   16. Francielle Pulcinelli Martins
   17. Samuel K. Shinjo
   18. Laiza Hombre Dias
   19. Michel A. Yazbek
   20. Felipe Omura
   21. Thiago H. S. Rached
   22. Ana Paula Monteiro Gomides
   23. Claudia Diniz Lopes Marques
   24. Gecilmara Cristina Salviato Pileggi
   25. Lícia M. H. Mota
   26. Marcelo Medeiros Pinheiro
   27. Odirlei André Monticielo
   28. Ricardo Machado Xavier
   29. Gilda Aparecida Ferreira

2. Damage Accrual in Patients with Systemic Lupus Erythematosus Predicts Mortality and Is Associated Primarily with Antiphospholipid Syndrome and Hypertension

   This article has 7 authors:

   1. Yael Pri-Paz Basson
   2. Hadar Haim-Pinhas
   3. Daniel Erez
   4. Iftach Sagy
   5. Keren Cohen-Hagai
   6. Shaye Kivity
   7. Oshrat E. Tayer-Shifman

3. Management of Asymptomatic Hyperleukocytosis Induced by Ibrutinib in a Patient with Chronic Lymphocytic Leukemia: A Case Study and Structured Follow-Up

   This article has 8 authors:

   1. H. A. Nati-Castillo
   2. Isabella Lara-Puello
   3. Andres David Sastre-Martínez
   4. Jhan Sebastian Saavedra-Torres
   5. María Alejandra Obando
   6. Rigoberto Gómez-Gutiérrez
   7. Marlon Arias-Intriago
   8. Juan S. Izquierdo-Condoy